Both in Pharmaceuticals
Rani Therapeutics Holdings vs Cingulate
Over the past year RANI returned −74.3% and CING returned +23.4%; their daily moves had a correlation of 0.12.
RANI −74.3% CING +23.4%Growth of $1, one year, split-adjusted
| Metric | RANI | CING |
|---|---|---|
| Price | $0.5534 | $4.69 |
| Market cap | $63.9M | $68.2M |
| Today | +0.29% | −6.76% |
| 1 month | −28.6% | −1.3% |
| 6 months | −37.4% | −5.8% |
| Year to date | −59.0% | +8.1% |
| 1 year | −74.8% | +23.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −432.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 13.1× | — |
| Net cash | $53.4M | $23.3M |
| Dividend yield | — | — |
| Volatility (60d) | 63.3% | 46.0% |
| Short % of float | 10.4% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).